BMP Signaling in Regenerative Medicine

View Sample PDF

Author(s): Julia Zimmer (Charité-Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Germany), Elisa Degenkolbe (Charité-Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Germany), Britt Wildemann (Charité-Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Germany)and Petra Seemann (Charité-Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Germany)
Copyright: 2013
Pages: 30
Source title: Bioinformatics: Concepts, Methodologies, Tools, and Applications
Source Author(s)/Editor(s): Information Resources Management Association (USA)
DOI: 10.4018/978-1-4666-3604-0.ch064

Keywords: Bioinformatics / Medical Information Science Reference / Medicine & Healthcare

Purchase

View BMP Signaling in Regenerative Medicine on the publisher's website for pricing and purchasing information.

Abstract

More than 40 years after the discovery of Bone Morphogenetic Proteins (BMPs) as bone inducers, a whole protein family of growth factors connected to a wide variety of functions in embryonic development, homeostasis, and regeneration has been characterized. Today, BMP2 and BMP7 are already used in the clinic to promote vertebral fusions and restoration of non-union fractures. Besides describing present clinical applications, the authors review ongoing trials highlighting the future possibilities of BMPs in medicine. Apparently, the physiological roles of BMPs have expanded their range from bone growth induction and connective tissue regeneration to cancer diagnosis/treatment and cardiovascular disease prevention.

The IRMA Community

Research IRM

BMP Signaling in Regenerative Medicine

Purchase

Abstract

Related Content

IRMA Sponsors